CDC42BPB
Basic information
Region (hg38): 14:102932380-103057549
Links
Phenotypes
GenCC
Source:
- complex neurodevelopmental disorder (Moderate), mode of inheritance: AD
- Chilton-Okur-Chung neurodevelopmental syndrome (Strong), mode of inheritance: AD
- Chilton-Okur-Chung neurodevelopmental syndrome (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Chilton-Okur-Chung neurodevelopmental syndrome | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic | 32031333 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn_genetic_diseases (147 variants)
- not_provided (136 variants)
- CDC42BPB-related_disorder (43 variants)
- Chilton-Okur-Chung_neurodevelopmental_syndrome (42 variants)
- not_specified (14 variants)
- CDC42BPB-related_neurodevelopmental_syndrome (12 variants)
- See_cases (6 variants)
- Neurodevelopmental_disorder (3 variants)
- Autism_spectrum_disorder (2 variants)
- EBV-positive_nodal_T-_and_NK-cell_lymphoma (1 variants)
- CDC42BPB-related_Neurodevelopmental_disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CDC42BPB gene is commonly pathogenic or not. These statistics are base on transcript: NM_000006035.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 30 | 38 | ||||
missense | 13 | 234 | 42 | 291 | ||
nonsense | 11 | |||||
start loss | 1 | 1 | ||||
frameshift | 7 | |||||
splice donor/acceptor (+/-2bp) | 5 | |||||
Total | 5 | 25 | 243 | 72 | 8 |
Highest pathogenic variant AF is 0.0000037233917
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CDC42BPB | protein_coding | protein_coding | ENST00000361246 | 37 | 125084 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 3.63e-12 | 125739 | 0 | 9 | 125748 | 0.0000358 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.66 | 686 | 1.01e+3 | 0.677 | 0.0000638 | 11188 |
Missense in Polyphen | 182 | 393.59 | 0.46241 | 4336 | ||
Synonymous | -0.553 | 433 | 419 | 1.03 | 0.0000295 | 3268 |
Loss of Function | 8.63 | 6 | 98.4 | 0.0610 | 0.00000557 | 1083 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000907 | 0.0000905 |
Ashkenazi Jewish | 0.0000996 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000619 | 0.0000527 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Serine/threonine-protein kinase which is an important downstream effector of CDC42 and plays a role in the regulation of cytoskeleton reorganization and cell migration. Regulates actin cytoskeletal reorganization via phosphorylation of PPP1R12C and MYL9/MLC2 (PubMed:21457715, PubMed:21949762). In concert with MYO18A and LURAP1, is involved in modulating lamellar actomyosin retrograde flow that is crucial to cell protrusion and migration (PubMed:18854160). Phosphorylates PPP1R12A (PubMed:21457715). In concert with FAM89B/LRAP25 mediates the targeting of LIMK1 to the lamellipodium resulting in its activation and subsequent phosphorylation of CFL1 which is important for lamellipodial F- actin regulation (By similarity). {ECO:0000250|UniProtKB:Q7TT50, ECO:0000269|PubMed:18854160, ECO:0000269|PubMed:21457715, ECO:0000269|PubMed:21949762}.;
Recessive Scores
- pRec
- 0.116
Intolerance Scores
- loftool
- 0.0187
- rvis_EVS
- -3.29
- rvis_percentile_EVS
- 0.42
Haploinsufficiency Scores
- pHI
- 0.248
- hipred
- Y
- hipred_score
- 0.707
- ghis
- 0.625
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.437
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cdc42bpb
- Phenotype
Gene ontology
- Biological process
- protein phosphorylation;cytoskeleton organization;establishment or maintenance of cell polarity;signal transduction;cell migration;actomyosin structure organization;actin cytoskeleton reorganization;intracellular signal transduction
- Cellular component
- cytoplasm;cytoskeleton;plasma membrane;cell-cell junction;lamellipodium;cell leading edge;actomyosin;extracellular exosome
- Molecular function
- magnesium ion binding;protein kinase activity;protein serine/threonine kinase activity;ATP binding;Rho GTPase binding;protein-containing complex binding